Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3879842 Target Snapshot

Sodium/hydrogen exchanger 3 · SINGLE PROTEIN · Rattus norvegicus

319Compounds
11Assays
2Approved Drugs
491.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P26433. Use UniProt P26433 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P26433 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Sodium/hydrogen exchanger 3 as ChEMBL target CHEMBL3879842, mapped to UniProt P26433. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Sodium/hydrogen exchanger 3
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-14
ChEMBL target ID
CHEMBL3879842
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P26433
Sodium/hydrogen exchanger 3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Sodium/hydrogen exchanger 3 is the right protein anchor across sources, using UniProt P26433 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelSodium/hydrogen exchanger 3
UniProt AccessionP26433
Component TypeProtein
Sequence Length831 aa

Sodium/hydrogen exchanger 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Sodium/hydrogen exchanger 3, mapped to UniProt P26433. Sequence length is 831 aa.

Mapped IDP26433
Review nameSodium/hydrogen exchanger 3
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
Assay Mix

Activity Type Distribution

IC50483.0
KI8.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3965282 9.2 IC50 0.631 Preclinical
CHEMBL3926527 8.9 IC50 1.259 Preclinical
CHEMBL3897251 8.85 IC50 1.413 Preclinical
CHEMBL3960838 8.7 IC50 1.995 Preclinical
CHEMBL3937928 8.6 IC50 2.512 Preclinical
CHEMBL3968241 8.6 IC50 2.512 Preclinical
CHEMBL3976660 8.6 IC50 2.512 Preclinical
CHEMBL3990220 8.6 IC50 2.512 Preclinical
CHEMBL3894457 8.5 IC50 3.162 Preclinical
CHEMBL3932620 8.4 IC50 3.981 Preclinical
Distribution

pChEMBL Value Distribution

18
5.0
27
5.5
54
6.0
67
6.5
91
7.0
81
7.5
42
8.0
13
8.5
2
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

TENAPANOR HYDROCHLORIDE
CHEMBL3301627
Approved 2019
TENAPANOR
CHEMBL3304485
Approved 2019
Assay Landscape

Assay Landscape

11
Total Assays
258
Tested Compounds
1
Assay Types
Binding — 11 assays, 258 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 9 254 7.0
single protein format 2 4 5.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine